- SCSK maintains its forecast for the fiscal year’s operating income at 85.00 billion yen, slightly below the market estimate of 85.93 billion yen.
- The company projects a net income of 63.50 billion yen, which is higher than the estimated 59.8 billion yen.
- Net sales are expected to reach 790.00 billion yen, just under the estimated figure of 790.75 billion yen.
- SCSK plans to keep its dividend at 94.00 yen per share, closely matching the estimated 94.18 yen.
- Analyst ratings for SCSK include 7 buy recommendations, 6 hold, and no sell recommendations.
A look at Scsk Corp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, SCSK Corp shows a promising long-term outlook. With a high Momentum score of 5, the company is seen as having strong positive price trends which may indicate potential for future growth. This is complemented by a solid Growth score of 4, suggesting that SCSK Corp is positioned for sustainable expansion. Additionally, the company demonstrates decent Resilience with a score of 3, indicating a level of stability and ability to weather economic challenges.
While the Value and Dividend scores for SCSK Corp are not as high, with scores of 2 each, the overall positive outlook is driven by the company’s strong performance in Growth and Momentum. As a provider of IT services including system solutions and software development, SCSK Corp is well-positioned to capitalize on the growing digital transformation trend, making it an intriguing prospect for long-term investors seeking growth opportunities in the technology sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
